Recursion Pharmaceuticals Hub
Utilizes AI and machine learning to discover new drugs for rare genetic diseases.
.png)
Investors
(Reupload).png)
Technology:
Artificial Intelligence, Biotechnology, Machine Learning, Pharmaceutical, Therapeutics
Industry:
AI, Artificial Intelligence, Biotechnology, Drug Repurposing, Machine Learning, Pharmaceutical, Therapeutics, United States
Headquarters:
Salt Lake City, Utah, United States
Founded Date:
2013-11-05
Employees Number:
101-250
Funding Status:
IPO
Acquisitions Number:
1
Investors Number:
34
Total Funding:
615376000
Estimated Revenue:
$10M to $50M
Last Funding Date:
2022-10-25
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership